Maryam Nikpour1, Mahdi Sepidarkish2, Shabnam Omidvar3, Mojgan Firouzbakht4. 1. Non-Communicable Pediatric Disease Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, I.R.Iran. 2. Department of Biostatistics and Epidemiology, School of Public Health, Babol University of Medical Sciences, Babol, I.R.Iran. 3. Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran. 4. Department of Nursing- Midwifery, Comprehensive Health Research Center, Babol Branch, Islamic Azad University, Babol, Iran.
Abstract
INTRODUCTION: We performed a systematic review and meta-analysis to evaluate the acceptance of a COVID-19 vaccine among pregnant women and its determinants. METHOD: We searched the bibliographic databases (Scopus, Medline, and Web of Science) for the relevant studies from 1 January 2020 to 11 July 2021. We pooled the prevalence of vaccine acceptance among pregnant women using a random-effects model and conducted subgroup analyses to explore its determinants. The result was expressed as a pooled prevalence percentage and adjusted odds ratio (aOR) with 95% CIs. RESULTS: We found ten studies that were suitable, with 16, 696 participants from 32 countries. COVID-19 vaccination acceptability in pregnant women was 54 percent globally (95% CI: 45, 62; I2= 99.05). There was no association between sociodemographic factors including age >35 years (aOR: 1.17, 95%CI: 0.95, 1.43), high education (aOR: 1.03, 95%CI: 0.79, 1.35), income levels (aOR: 1.18, 95%CI: 0.80, 1.75), knowledge scores (aOR: 2.55, 95% CI: 0.78, 8.34) and COVID-19 vaccine acceptance. CONCLUSION: About half of pregnant women accepted the COVID-19 vaccine. We did not find any association between sociodemographic factors and COVID-19 vaccine acceptance. However, these findings should be considered with caution due to small number of studies and the substantial heterogeneity between them.
INTRODUCTION: We performed a systematic review and meta-analysis to evaluate the acceptance of a COVID-19 vaccine among pregnant women and its determinants. METHOD: We searched the bibliographic databases (Scopus, Medline, and Web of Science) for the relevant studies from 1 January 2020 to 11 July 2021. We pooled the prevalence of vaccine acceptance among pregnant women using a random-effects model and conducted subgroup analyses to explore its determinants. The result was expressed as a pooled prevalence percentage and adjusted odds ratio (aOR) with 95% CIs. RESULTS: We found ten studies that were suitable, with 16, 696 participants from 32 countries. COVID-19 vaccination acceptability in pregnant women was 54 percent globally (95% CI: 45, 62; I2= 99.05). There was no association between sociodemographic factors including age >35 years (aOR: 1.17, 95%CI: 0.95, 1.43), high education (aOR: 1.03, 95%CI: 0.79, 1.35), income levels (aOR: 1.18, 95%CI: 0.80, 1.75), knowledge scores (aOR: 2.55, 95% CI: 0.78, 8.34) and COVID-19 vaccine acceptance. CONCLUSION: About half of pregnant women accepted the COVID-19 vaccine. We did not find any association between sociodemographic factors and COVID-19 vaccine acceptance. However, these findings should be considered with caution due to small number of studies and the substantial heterogeneity between them.
Entities:
Keywords:
COVID-19; COVID-19 vaccination; acceptance; pregnant women
Authors: Shannon E MacDonald; Laura Reifferscheid; Julie A Bettinger; Joan Robinson; Manish Sadarangani; Eve Dubé; Noni E MacDonald; Emmanuel Marfo; Ali Assi; Arnaud Gagneur; S Michelle Driedger Journal: Can J Public Health Date: 2022-08
Authors: Jude Mary Cénat; Pari-Gole Noorishad; Seyed Mohammad Mahdi Moshirian Farahi; Wina Paul Darius; Aya Mesbahi El Aouame; Olivia Onesi; Cathy Broussard; Sarah E Furyk; Sanni Yaya; Lisa Caulley; Marie-Hélène Chomienne; Josephine Etowa; Patrick R Labelle Journal: J Med Virol Date: 2022-09-16 Impact factor: 20.693